- Home
- INVE vs ANIX Comparison
INVE vs ANIX Comparison
Compare INVE & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- ANIX
- Stock Information
- Founded
- INVE 1990
- ANIX 1982
- Country
- INVE United States
- ANIX United States
- Employees
- INVE N/A
- ANIX N/A
- Industry
- INVE Computer peripheral equipment
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- INVE Technology
- ANIX Health Care
- Exchange
- INVE Nasdaq
- ANIX Nasdaq
- Market Cap
- INVE 74.2M
- ANIX 108.9M
- IPO Year
- INVE 1997
- ANIX 1987
- Fundamental
- Price
- INVE $3.28
- ANIX $3.21
- Analyst Decision
- INVE Strong Buy
- ANIX Strong Buy
- Analyst Count
- INVE 3
- ANIX 3
- Target Price
- INVE $6.50
- ANIX $9.00
- AVG Volume (30 Days)
- INVE 72.1K
- ANIX 246.1K
- Earning Date
- INVE 08-07-2025
- ANIX 05-28-2025
- Dividend Yield
- INVE N/A
- ANIX N/A
- EPS Growth
- INVE N/A
- ANIX N/A
- EPS
- INVE 3.12
- ANIX N/A
- Revenue
- INVE $25,239,000.00
- ANIX N/A
- Revenue This Year
- INVE N/A
- ANIX N/A
- Revenue Next Year
- INVE $9.00
- ANIX N/A
- P/E Ratio
- INVE $1.06
- ANIX N/A
- Revenue Growth
- INVE N/A
- ANIX N/A
- 52 Week Low
- INVE $2.86
- ANIX $2.07
- 52 Week High
- INVE $4.35
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- INVE 54.23
- ANIX 50.82
- Support Level
- INVE $3.10
- ANIX $3.18
- Resistance Level
- INVE $3.25
- ANIX $3.39
- Average True Range (ATR)
- INVE 0.12
- ANIX 0.20
- MACD
- INVE 0.01
- ANIX -0.05
- Stochastic Oscillator
- INVE 71.43
- ANIX 9.23
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.